Skip to main content
Caplight Logo









CereCura Nanotherapeutics

CereCura Nanotherapeutics

Private
VancouverHealthcare & Life Scienceshttps://www.cerecura.com/

Last Round

Seed

Nov 14, 2025

Total Funding Raised

$1.81M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

CereCura Nanotherapeutics is a biotechnology company that develops lipid nanoparticle-based RNA therapeutics to treat neurological disorders by enabling the brain to synthesize its own therapeutic proteins.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

lipid nanoparticleLNPRNA therapeuticsblood-brain barrierneurological disordersdrug deliverynanomedicinebiotech startuppreclinical biotechgene therapyCNS drug deliverytherapeutic proteinbiotech R&Dnon-dilutive funding

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CereCura Nanotherapeutics Comparables

Compare CereCura Nanotherapeutics with similar companies based on industry and business-model similarity.

CereCura Nanotherapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QurCan Therapeutics
86%
Aerska
81%
Gate2Brain
79%

CereCura Nanotherapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 14, 2025

Key People

Founding team and executive leadership

Louis-Philippe Bernier

Chief Executive Officer at CereCura Nanotherapeutics

Executive Team

CereCura Nanotherapeutics Investors

Notable investors and investment history

CereCura Nanotherapeutics investors
InvestorRounds
E-FundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors increased 85% MoM.

  • Nov 14, 2025

    $1M round led by wutif-capital

CereCura Nanotherapeutics Filings

Explore SEC and related filing metadata, where available.

CereCura Nanotherapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CereCura Nanotherapeutics's valuation, stock price, and market status.

Is CereCura Nanotherapeutics a public or private company?

CereCura Nanotherapeutics is a private company.

What is the current stock price of CereCura Nanotherapeutics?

CereCura Nanotherapeutics is a private company with no public stock price. Caplight tracks CereCura Nanotherapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is CereCura Nanotherapeutics worth (valuation)?

Valuation information for CereCura Nanotherapeutics is not publicly available.

Can I buy CereCura Nanotherapeutics stock?

CereCura Nanotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CereCura Nanotherapeutics's last funding round?

CereCura Nanotherapeutics's most recent funding round was Seed on November 14, 2025.

Who are the main investors in CereCura Nanotherapeutics?

Key investors in CereCura Nanotherapeutics include E-Fund.

Will CereCura Nanotherapeutics IPO soon?

No public IPO plans have been announced for CereCura Nanotherapeutics.

How can I track CereCura Nanotherapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CereCura Nanotherapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersVancouver
Employee Range9
Year Founded2022
Last FundingNov 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?